Skip to content

IMPROVE - International Survey for Endometrial Cancer patients: perspective and expectation on therapy and quality of life (Expression XI)

IMPROVE - International Survey for Endometrial Cancer patients: perspective and expectation on therapy and quality of life (Expression XI) - EXPRESSION XI

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00025954
Enrollment
1600
Registered
2021-07-27
Start date
2021-08-08
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial cancer

Interventions

Group 1: All patients were asked to complete the study questionnaire once.

Sponsors

Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie e.V.
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with a diagnosis of endometrial carcinoma (primary or relapsed). A minimum age of 18 years years is required.

Exclusion criteria

Exclusion criteria: Patients with other tumours and patients under 18 years of age.

Design outcomes

Primary

MeasureTime frame
The main objective of the study is to examine the risk factors and general lifestyle of the patients (comorbidities, health status, polypharmacy, symptoms and quality of life or psychosocial stress), including all women with primary and recurrent endometrial cancer, regardless of disease and treatment status.

Secondary

MeasureTime frame
In addition, the patient's own perception and expectations of the (maintenance) therapy and aftercare will be assessed.

Countries

Austria, Belgium, Czechia, Denmark, Egypt, Finland, France, Germany, Italy, Romania, Saudi Arabia, Slovakia, Slovenia, Spain, Switzerland, Ukraine, United States

Contacts

Public ContactJolijn Boer

Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie e.V.

jolijn.boer@noggo.de030403686534

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 30, 2026